BenevolentAI Patents

Patent portfolio assigned to BenevolentAI (verified via public assignee records). AstraZeneca (strategic drug-discovery collaboration, 2019+) and Janssen/J&J (exclusive license deal) are named partners on BenevolentAI's own site and PR. has_patents=true: acquired Janssen's drug-candidate patent portfolio plus owns drug-target IP (per PR). Exact count not retrieved; patents.google.com was rate-limited (HTTP 503).